These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 38174181)

  • 1. Impact of Proton Pump Inhibitors on Kidney Function and Chronic Kidney Disease Progression: A Systematic Review.
    Parmar MP; Kaleem S; Samuganathan P; Ishfaq L; Anne T; Patel Y; Bollu S; Vempati R
    Cureus; 2023 Dec; 15(12):e49883. PubMed ID: 38174181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review.
    Cheema E
    J Pharm Policy Pract; 2019; 12():6. PubMed ID: 30976431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Community-dwelling older adults' awareness of the inappropriate use of proton pump inhibitors.
    Rababa M; Rababa'h A
    BMC Geriatr; 2020 Oct; 20(1):431. PubMed ID: 33121444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
    Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
    Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury.
    Hatakeyama Y; Horino T; Matsumoto T; Terada Y; Okuhara Y
    Clin Exp Nephrol; 2021 Oct; 25(10):1087-1092. PubMed ID: 34089392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton Pump Inhibitors and the Kidney: Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.
    Al-Aly Z; Maddukuri G; Xie Y
    Am J Kidney Dis; 2020 Apr; 75(4):497-507. PubMed ID: 31606235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term kidney outcomes among users of proton pump inhibitors without intervening acute kidney injury.
    Xie Y; Bowe B; Li T; Xian H; Yan Y; Al-Aly Z
    Kidney Int; 2017 Jun; 91(6):1482-1494. PubMed ID: 28237709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
    Hart E; Dunn TE; Feuerstein S; Jacobs DM
    Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease.
    Klatte DCF; Gasparini A; Xu H; de Deco P; Trevisan M; Johansson ALV; Wettermark B; Ärnlöv J; Janmaat CJ; Lindholm B; Dekker FW; Coresh J; Grams ME; Carrero JJ
    Gastroenterology; 2017 Sep; 153(3):702-710. PubMed ID: 28583827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
    Targownik LE; Fisher DA; Saini SD
    Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton Pump Inhibitors and Risk of Chronic Kidney Disease: Evidence from Observational Studies.
    Wu CC; Liao MH; Kung WM; Wang YC
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.
    Thurber KM; Otto AO; Stricker SL
    Am J Health Syst Pharm; 2023 Apr; 80(8):487-494. PubMed ID: 36629265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump inhibitors are associated with increased risk of development of chronic kidney disease.
    Arora P; Gupta A; Golzy M; Patel N; Carter RL; Jalal K; Lohr JW
    BMC Nephrol; 2016 Aug; 17(1):112. PubMed ID: 27487959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitor use and progression to major adverse renal events: a competing risk analysis.
    Grant CH; Gillis KA; Lees JS; Traynor JP; Mark PB; Stevens KI
    QJM; 2019 Nov; 112(11):835-840. PubMed ID: 31251364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation of Proton Pump Inhibitors in Patients With Chronic Kidney Disease.
    Mertz A; Cooney D; Rahman M; Lacey C; Burant CJ; Desai N
    Hosp Pharm; 2021 Aug; 56(4):308-313. PubMed ID: 34381266
    [No Abstract]   [Full Text] [Related]  

  • 17. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing.
    Dharmarajan TS
    J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of proton pump inhibitors and macrolide antibiotics and risk of acute kidney injury: a self-controlled case series study.
    Ikuta K; Nakagawa S; Yamawaki C; Itohara K; Hira D; Imai S; Yonezawa A; Nakagawa T; Sakuragi M; Sato N; Uchino E; Yanagita M; Terada T
    BMC Nephrol; 2022 Nov; 23(1):383. PubMed ID: 36451129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression.
    Scarpignato C; Gatta L; Zullo A; Blandizzi C; ;
    BMC Med; 2016 Nov; 14(1):179. PubMed ID: 27825371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AGA Clinical Practice Update on the Personalized Approach to the Evaluation and Management of GERD: Expert Review.
    Yadlapati R; Gyawali CP; Pandolfino JE;
    Clin Gastroenterol Hepatol; 2022 May; 20(5):984-994.e1. PubMed ID: 35123084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.